Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis

被引:0
作者
John P. ONeill
Cathal S Clifford
Niamh P. Nolan
P. Aiden McCormick
机构
[1] St Vincent’s University Hospital,Department of Histopathology
[2] St Vincent’s University Hospital,Liver Unit
[3] University College Dublin,undefined
来源
Irish Journal of Medical Science (1971 -) | 2023年 / 192卷
关键词
Cirrhosis; Esophageal varices; Idiopathic portal hypertension; Nodular regenerative hyperplasia; Non-cirrhotic portal hypertension;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1657 / 1660
页数:3
相关论文
共 50 条
[1]  
Boelle PY(2019)Cystic fibrosis liver disease: outcomes and risk factors in a large cohort of French patients Hepatology 69 1648-1656
[2]  
Debray D(2016)Cystic fibrosis Lancet 388 2519-2531
[3]  
Guillot L(2019)The emerging burden of liver disease in cystic fibrosis patients: a UK nationwide study PLoS ONE 14 e0212779-400
[4]  
Elborn JS(2022)Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis Aliment Pharmacol Ther 55 389-599
[5]  
Toledano MB(2021)Emerging clinical perspectives in cystic fibrosis liver disease Curr Opin Pulm Med 27 593-1382
[6]  
Mukherjee SK(2002)Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome Hepatology 36 1374-1347
[7]  
Howell J(2017)Liver transplantation in adult cystic fibrosis: clinical, imaging, and pathological evidence of obliterative portal venopathy Liver Transpl 23 1342-1065
[8]  
Scott J(2011)Noncirrhotic presinusoidal portal hypertension is common in cystic fibrosis-associated liver disease Hepatology 53 1064-2136
[9]  
Jones AM(2019)Obliterative portal venopathy without cirrhosis is prevalent in pediatric cystic fibrosis liver disease with portal hypertension Clin Gastroenterol Hepatol 17 2134-e13
[10]  
Piper Hanley K(2017)Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension J Cyst Fibros 16 e11-126